Dr. Reddy's Laboratories Limited

RDY | NYSE

$12.61

+$0.21 (+1.69%)

Sep 22, 2026, 1:31 PM ET · Market open

Fiscal Year Period Ending	FY 2026 Mar 30, 2026	FY 2025 Mar 30, 2025	FY 2024 Mar 30, 2024	FY 2023 Mar 30, 2023	FY 2022 Mar 30, 2022	FY 2021 Mar 30, 2021
Revenue	353.47B	325.54B	279.16B	245.88B	214.39B	2.56B
Cost of Revenue	166.95B	135.11B	115.56B	106.54B	100.55B	1.26B
Gross Profit	186.52B	190.43B	163.61B	139.34B	113.84B	1.3B
Operating Income	48.87B	71.84B	67.73B	57.14B	29.48B	431.44M
Interest Income	8.28B	2.68B	2.28B	1.18B	965M	826M
Pretax Income	57.68B	76.78B	71.87B	60.37B	32.3B	355.8M
Net Income	45.09B	56.54B	55.68B	45.07B	23.57B	232.21M
Selling & General & Admin	112.34B	93.87B	77.2B	68.03B	62.08B	659.9M
Research & Development	25.31B	27.38B	22.87B	19.38B	17.48B	208.37M
Other Expenses	n/a	-2.67B	-4.2B	-5.21B	4.8B	1.91M
Operating Expenses	137.65B	118.59B	95.88B	82.2B	84.36B	866.36M
Interest Expense	3.93B	2.83B	1.71B	1.43B	958M	970M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	304.6B	253.69B	211.44B	188.74B	184.92B	2.12B
Income Tax Expense	13B	19.54B	16.19B	15.3B	8.73B	123.59M
Shares Outstanding (Basic)	832.41M	833.31M	833.54M	830.17M	829.41M	829.22M
Shares Outstanding (Diluted)	833.26M	834.3M	833.54M	831.91M	831.69M	831.58M
EPS (Basic)	53.92	67.85	66.80	54.29	28.42	20.79
EPS (Diluted)	53.92	67.77	66.80	54.17	28.34	20.73
EBITDA	83.29B	96.67B	88.42B	74.43B	45.08B	534.77M
EBIT	61.61B	79.61B	73.58B	61.8B	33.26B	362.4M
Depreciation & Amortization	21.68B	17.06B	14.84B	12.64B	11.82B	172.37M